We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy
FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy
Immunomedic’s Trodelvy (sacituzumab govitecan-hziy) earned accelerated approval for treatment of adults with triple-negative breast cancer that has metastasized.